Skip to content
Medifast logo

Medifast

MED

Medifast is a health and wellness company that provides a science-backed, coach-guided lifestyle system focused on metabolic health and sustainable weight loss.

Market cap
$110.19M-22.6%
Revenue$346.1M-36.3%
Net income-$20.0M-186%
Free cash flow$7.0M-79.2%
EPS (diluted)-$1.83-182%
Trailing twelve months · change vs. prior year

Earnings

Next report

Aug 3, 2026 (Today)
Revenue estimate$72.7M
EPS estimate-$0.65

Financials

Q1 2026

Income statement

See full
Revenue$76.0M-34.3%
Gross profit$51.8M-38.6%
Operating income-$3.3M-161%
Net income-$2.1M-175%
EPS (diluted)-$0.19-171%

Balance sheet

See full
Cash & equivalents$71.5M-22.0%
Total debt$16.1M+10.2%
Total equity$197.7M-6.3%
Total assets$252.0M-10.0%

Cash flow

See full
Operating cash flow$260.0K-92.4%
CapEx$1.1M-28.0%
Free cash flow-$836.0K-144%

Valuation & ratios

Valuation

See full
Market cap$110.19M-22.6%
Enterprise value$54.76M-12.7%
P/S0.3×0.0×

Profitability

See full
Gross margin70.1%-3.8pp
Operating margin-4.7%-7.0pp
Net margin-5.8%-8.1pp

Returns & leverage

See full
Return on equity-9.8%-20.1pp
Debt / equity0.1×0.0×
Current ratio4.8×+1.3×

Segments

By segment

See full
Optavia Segment$76.0M-34.3%

Competitors

Profile

Medifast is a health and wellness company that provides a science-backed, coach-guided lifestyle system focused on metabolic health and sustainable weight loss. The company leverages a direct-to-consumer model centered on independent coaches who provide personalized support, community engagement, and proprietary nutritional products. Its core value proposition lies in addressing the root causes of metabolic dysfunction through a holistic framework of habit creation and clinically proven nutrition plans.

Competitive position

A leading provider of coach-supported metabolic health solutions that differentiates itself from traditional diet companies through a 'coach-first' model and a focus on lean muscle preservation.

GeographiesUnited States, Hong Kong, China
Customer segmentsB2C, Metabolically unhealthy adults, Weight loss medication patients
Business modelDirect-to-consumer, Direct selling, Subscription-based auto-ship
SuppliersRaw material suppliers, Commodity providers, Third-party co-manufacturers, Logistics and shipping providers
CustomersIndependent OPTAVIA coaches, Direct-to-consumer retail clients
Listed1981
Employees634.0
CEONicholas Johnson
FilingsSEC EDGAR

Questions, answered.

What is Medifast's market cap?
Medifast (MED) has a market capitalization of $110.2M and trades on NYSE.
What is Medifast's revenue and profitability?
Medifast generated $346.1M in trailing twelve-month revenue with a net loss of $20.0M, representing a net margin of -5.8%. Gross margin stands at 70.1%, with free cash flow of $7.0M. These figures are based on the Q1 2026 filing.
Who are Medifast's competitors?
Medifast's key competitors include WW International, Inc., Herbalife Ltd., Eli Lilly and Company, and others. These companies compete in similar markets and product categories.
Who does Medifast partner with?
Medifast's notable partners include Meta, TikTok, X.
What subsidiaries does Medifast have?
Medifast's subsidiaries include Jason Pharmaceuticals, Inc., OPTAVIA LLC, Jason Enterprises, Inc., and others.
Where is Medifast headquartered?
Medifast is headquartered in United States of America and employs approximately 634 people. It has been publicly traded since 1981.